Last reviewed · How we verify
NCT06338761: E-cig-PCI
Switching to E-cigarette After PCI
trial testing Smoking cessation in Coronary Artery Disease in 17,973 participants. Completed in 15 March 2025.
31 December 2024
Quick facts
| Lead sponsor | Samsung Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 17,973 |
| Start date | 1 January 2024 |
| Primary completion | 31 December 2024 |
| Estimated completion | 15 March 2025 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Smoking cessation
- Switching to E-cigarette
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Samsung Medical Center
Who can join
20 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Despite the increasing popularity of electronic cigarettes (E-cigarettes), the prognostic impact of switching to E-cigarettes in smokers with coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI) remains uncertain.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
Kang D, Choi KH, Kim H, Park H, et al · · 2025 · cited 15× · PMID 39429032 · DOI 10.1093/eurheartj/ehae705
Verify or expand the search:
- PubMed search for NCT06338761
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Smoking cessation
Trials testing the same drug.
- NCT05196282 — Influence of Smoking Cessation or Switching to THS on Disease Activity in IBD Patients. · unknown
- NCT05107687 — Effectiveness of Smoking Cessation Program in a Community Health System · unknown
- NCT04265339 — The Interplay Between Addiction to Tobacco Smoking and Sleep Quality Among Healthy Adults · NA · unknown
- NCT03099811 — Financial Incentives to Reduce Pediatric Tobacco Smoke Exposures · NA · completed
- NCT03562442 — SAW Lung Microbiome Study in Smokers and Never-smokers · NA · completed
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Samsung Medical Center trials
Trials by the same sponsor.
- NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
- NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
- NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
- NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
- NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06338761 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
- Last refreshed: 21 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06338761.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing